哈特福德二季度电话会重申42亿美元回购授权并计划年内每季回购4.75亿美元

Earnings Call Insights: The Hartford (HIG) Q2 2026
Christopher Swift (Chairman & CEO) said, "During the quarter, we announced an agreement to sell The Hartford Funds to Wellington Management, strategically monetizing a non-core long-term investment." Swift also said, "our Board of Directors approved a new share repurchase authorization of $4.2 billion" and added, "We will continue to balance growth, investing in our businesses and returning excess capital to shareholders through repurchases and dividends."
Swift highlighted segment execution and capital returns, stating, "Business Insurance delivered strong written premium growth of 5% with an underlying combined ratio of 89.3%." He added, "Employee Benefits had another quarter of strong premium growth, with a core earnings margin of 7.4%," and said the quarter "contributed to core earnings of $945 million and an outstanding core earnings ROE of 18.7% over the trailing 12 months."
Beth Bombara (Executive VP & CFO) said, "Core earnings for the quarter were $945 million or $3.42 per diluted share with a trailing 12-month core earnings ROE of 18.7%." She added, "Book value per share, excluding AOCI, of $78.91 increased 7% from year-end and 15% from a year ago reflecting the earnings power of our businesses and disciplined approach to capital management."
Beth Bombara (Executive VP & CFO) said, "Looking ahead to the second half of 2026, we expect limited partnership returns to remain generally consistent with the average annualized return achieved in the first half of the year, although further geopolitical and economic volatility could affect results." She added, "For full year 2026, given the current market conditions, we continue to expect net investment income to increase, supported by growth in invested assets with overall portfolio yields expected to remain broadly in line with 2025."
Compared with Q1 2026’s repurchase pace of "$450 million" expected to continue into Q2, Bombara said in Q2 2026, "We expect to increase our quarterly repurchases to $475 million through the remainder of 2026."
Christopher Swift (Chairman & CEO) pushed back on framing expense targets as formal guidance, telling an analyst, "We're not providing guidance. These are goals that we've set for the organization. We're not in the guidance game."
Beth Bombara (Executive VP & CFO) reported net investment income of "$800 million, up $142 million or 22% from the second quarter of 2025," and said, "Excluding limited partnerships, the annualized portfolio yield was 4.7% before tax, up 20 basis points from the first quarter."
Bombara detailed reserve and loss items affecting underwriting lines, saying, "General liability reserves were increased in the quarter primarily to reflect a higher frequency of large losses in excess casualty and umbrella lines across multiple accident years" and "Commercial auto liability reserves were increased primarily due to adverse loss development within accident years 2023 and 2024, driven by higher severity than previously estimated." She added, "With respect to catastrophes, P&C current accident year losses were $222 million before tax, up from $212 million in the prior year while the catastrophe ratio remained unchanged at 4.9% combined ratio points."
Bombara described capital actions and authorizations: "Yesterday, the Board of Directors approved a new share repurchase authorization of $4.2 billion effective through December 2028," and said it was "in addition to the existing authorization, which as of June 30, had approximately $650 million remaining." She added, "During the quarter, we repurchased 3.4 million shares for $450 million."
Andrew Kligerman, TD Cowen: Asked if reserve actions in workers’ comp, general liability, and commercial auto were one-time or could become chronic; Beth Bombara (Executive VP & CFO) replied, "increased prior year reserves by $46 million" in general liability due to "elevated large loss activity," and said commercial auto reflected "more attorney involvement" and workers’ comp continued to show favorability.
Andrew Kligerman, TD Cowen: Asked if disability loss ratio pressure could rise; Christopher Swift (Chairman & CEO) said, "our 6% to 7% long-term margin has always been the view," and Michael Fish (Executive VP & Head of Employee Benefits) said, "we're seeing higher incidence" and that "behavioral health claims are up a bit" while PFML utilization was higher in new and existing states.
Brian Meredith, UBS: Asked to unpack commercial lines loss ratio and mix; Beth Bombara (Executive VP & CFO) declined a full breakdown but said, "We expect the full year to probably come in roughly a point better" than the year-to-date MLC underlying combined ratio of "93.3%" if non-CAT property "evens out"; Adin Tooker (President) said commercial auto premium being up was "not... a change in strategy" and national accounts are generally "loss picks... less than $5 million."
Michael Zaremski, BMO: Asked if forward loss trend assumptions changed; Beth Bombara (Executive VP & CFO) said, "very, very minor impact" and "It's tenths of basis points." On competition and pricing, Swift gave renewal pricing details and said, "where we can, we'll step away."
Charles Peters, Raymond James: Pressed on large property exposure and later personal lines growth; Swift said the large property book was "about $200 million" and Tooker said shared/layered large property was "less than $25 million"; on personal lines, Swift said, "we expect a little bit of headwinds, particularly in direct as we head into '27," while Melinda Thompson (Head of Personal Lines) said growth will be "bifurcated" with agency encouraged by progress.
Taylor Scott, Barclays: Asked about capital strategy and reserve review consistency; Bombara said the new authorization was "a $900 million increase or 27% increase" vs. the prior $3.3B, and on reserves said, "No, I wouldn't call out anything being different."
Katie Sakys, Autonomous Research: Asked about expense ratio goals and small commercial competition; Swift responded, "I continue to be optimistic in business insurance and employee benefits" but said Personal Insurance faced "increasing pressure" to hit goals; Tooker said small business "Flow... remains really strong" and he felt "confident" on maintaining margins.
David Motemaden, Evercore ISI: Asked GL accident years and non-CAT property expectations; Bombara said GL activity included "2017, '18, '19... and also in '22, '23" and "We did not add anything to '25"; she said non-CAT property "came in a little bit under... what we would have anticipated" due to "a couple of large fire losses."
Elyse Greenspan, Wells Fargo: Asked about AI benefits and M&A stance; Swift said AI focus includes "underwriting operations" and "claims" and Tooker added, "We haven't disclosed any KPIs"; on M&A, Swift said, "we'd like to grow organically" and "there's nothing, obviously, to announce today."
Robert Cox, Goldman Sachs: Asked about middle & large retention and Global Specialty pricing; Tooker said retention was "entirely market-driven" amid "increasing competition"; he said Global Specialty pricing reflected "less negative rates internationally" and "wholesale overall... ticked up nicely."
Analysts were slightly negative to pressing, repeatedly probing reserve adequacy, casualty trends, and competition, including questions about whether reserve issues could become "chronic" and whether review methods were "different" versus prior years.
Management tone was slightly positive in prepared remarks and more technical/defensive in Q&A, emphasizing reserve process discipline (Bombara: "we look at our reserves every quarter") and selectivity under competition (Swift: "where we can, we'll step away").
Versus Q1 2026, Q2 carried more skepticism around casualty reserve development (general liability and commercial auto) and disability incidence, while management maintained similar confidence in underwriting discipline and technology investments.
Q2 introduced a major strategic/capital item not present in Q1: Swift said the company agreed to sell Hartford Funds and announced a new "$4.2 billion" repurchase authorization; Q1 discussed remaining capacity on an authorization through 2026.
The focus of analyst questioning broadened from Q1 pricing-cycle durability and catastrophe seasonality to Q2 reserve development detail, including multi-accident-year general liability and 2023–2024 commercial auto severity and attorney involvement.
Q2 management language highlighted competitive pressure more explicitly in Middle & Large retention and personal lines direct channel headwinds, while reiterating small business differentiation and continued AI/technology investment.
Beth Bombara (Executive VP & CFO) cited drivers of adverse reserve development: "a higher frequency of large losses" in excess casualty/umbrella and commercial auto severity with "increasing attorney representation and time limit demand."
Employee Benefits risk discussion centered on disability incidence and PFML utilization; Michael Fish (Executive VP & Head of Employee Benefits) said, "we're seeing utilization up" and added, "we'll continue to put rate on top of that book."
Competitive pressure was flagged as a growth constraint; Adin Tooker (President) said the company would "continue to make choices and not grow if we see the competitive dynamic going too far."
Management emphasized that Q2 2026 combined strong segment results with a major capital return update tied to the Hartford Funds sale, including a new $4.2B repurchase authorization and a plan to lift quarterly buybacks to $475M through the rest of 2026. In Q&A, executives repeatedly framed unfavorable reserve actions in general liability and commercial auto as modest, data-driven adjustments within a consistent quarterly review process, while acknowledging competitive pressure (particularly in Middle & Large and direct personal lines) and pointing to ongoing underwriting discipline and technology investment as key operating levers.